Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a ...

Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

The companies will develop and commercialize diagnostic tools to help clinicians determine which patients would benefit from precision medicine treatments.

"Our partnership with Danaher and [Danaher subsidiary] Leica Biosystems underscores our commitment to pioneering AI-based diagnostics which can improve patient selection, and our belief that ...

GTS Securities dramatically reduced its Danaher holdings by nearly 90% in the fourth quarter, raising eyebrows across Wall ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Danaher and AstraZeneca have formed a partnership to develop diagnostic tools that help clinicians better determine which patients would benefit from precision medicine treatments.

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid ...

Gordian Capital Singapore supercharged its Danaher holdings by 400% last quarter, pushing its stake to $1.61 million. Other ...

Danaher Corp. closed 32.84% short of its 52-week high of $281.70, which the company reached on August 1st.

Danaher Corp. closed 34.49% below its 52-week high of $281.70, which the company achieved on August 1st.

Shares of Danaher Corp. slipped 5.54% to $186.81 Wednesday, on what proved to be an all-around poor trading session for the ...